ALLMedicine™ Growth Hormone Deficiency Center
Research & Reviews 761 results
https://clinicaltrials.gov/ct2/show/NCT02311322
May 20th, 2022 - Children often present to pediatricians and pediatric endocrinologists because of abnormal body growth, including both childhood growth failure and, less commonly, overgrowth. Sometimes the cause is evident, for example, growth hormone deficiency ...
https://doi.org/10.1177/00099228221096654
Clinical Pediatrics; Gizli Çoban Ö, Bedel A et. al.
May 19th, 2022 - In this study, we aimed to investigate psychiatric disorders, bullying/victimization, and quality of life in children and adolescents with idiopathic growth hormone deficiency (GHD). Sixty-one children and adolescents who were diagnosed as having ...
https://doi.org/10.1007/s40618-022-01808-4 10.1016/j.ghir.2021.101392 10.1210/jc.2015-3256 10.1210/jcem.85.11.6984 10.1159/000452150 10.4274/jcrpe.galenos.2020.2019.0218 10.1111/jpc.14061 10.1007/s40618-015-0418-0 10.1159/000101427 10.1159/000448553 10.1159/000049976 10.1136/bmj.325.7355.70 10.1210/jc.2005-2284 10.1159/000329161 10.1159/000351800 10.1159/000139149 10.1530/EC-17-0277 10.1530/EJE-16-1024 10.1007/s40618-017-0816-6 10.1016/j.endinu.2018.11.007 10.1007/s12020-019-02057-x 10.1159/000339468 10.1530/eje.0.1440013 10.1136/bmj.315.7110.708 10.1159/000452887 10.1157/13120692 10.1111/j.1651-2227.2008.01053.x 10.1210/jc.2007-1581 10.1007/s40618-020-01218-4 10.1055/s-0034-1395665 10.1159/000071227 10.1186/1472-6947-7-40 10.1159/000363106 10.3389/fendo.2019.00792 10.3389/fendo.2021.678094 10.1002/sim.2227 10.1136/archdischild-2014-307228 10.1007/s40618-021-01541-4
Journal of Endocrinological Investigation; Lonero A, Giotta M et. al.
May 15th, 2022 - We aimed to evaluate the near-final height (nFHt) in a large cohort of pediatricpatients with growth hormone deficiency (GHD) and to elaborate a new predictive method of nFHt. We recruited GHD patients diagnosed between 1987 and 2014 and followed-...
https://doi.org/10.1007/s11102-022-01225-z 10.1016/S2213-8587(16)00086-3 10.1016/j.beem.2017.03.002 10.1038/nrendo.2013.5 10.1016/S2213-8587(21)00235-7 10.1046/j.1365-2265.2004.01976.x 10.1530/eje.0.1460067 10.1210/jc.2009-0806 10.1530/EJE-09-0836 10.1046/j.1365-2265.2003.01922.x 10.1046/j.1365-2265.1999.00738.x 10.1530/eje.1.02329 10.1111/j.1365-2265.2004.02004.x 10.4158/GL-2019-0405 10.1530/EJE-11-0942 10.1111/j.1365-2265.2005.02244.x 10.1111/j.1365-2265.2004.02018.x
Pituitary Boguszewski CL
May 14th, 2022 - Several complications associated with active Cushing's disease may persist even years after complete and successful therapeutic remission of hypercortisolism. Growth hormone deficiency (GHD) shares many clinical features seen in patients with Cush...
https://doi.org/10.1016/j.psyneuen.2022.105786
Psychoneuroendocrinology Tang J, Xia Y et. al.
May 14th, 2022 - This study aimed to explore the disparities in dynamic brain networks between children with growth hormone deficiency (GHD) and idiopathic short stature (ISS, non-growth hormone deficiency). This study enrolled 65 children with GHD and 60 sex- and...
Guidelines 1 results
https://doi.org/10.1227/NEU.0000000000001387
Neurosurgery Fleseriu M, Bodach ME et. al.
Sep 17th, 2016 - Nonfunctioning pituitary adenomas (NFPAs) are among the most common pituitary lesions and may present with hypopituitarism and/or hyperprolactinemia. To review the existing literature as it pertains to preoperative endocrine assessment in the work...
Drugs 14 results see all →
Clinicaltrials.gov 42 results
https://clinicaltrials.gov/ct2/show/NCT02311322
May 20th, 2022 - Children often present to pediatricians and pediatric endocrinologists because of abnormal body growth, including both childhood growth failure and, less commonly, overgrowth. Sometimes the cause is evident, for example, growth hormone deficiency ...
https://clinicaltrials.gov/ct2/show/NCT05334563
Apr 27th, 2022 - Background Congenital combined pituitary hormone deficiency (cCPHD) is defined as the partial or complete loss of more than one hormone secreted from the pituitary gland, caused by genetic or prenatal factors. Combined pituitary hormone deficiency...
https://clinicaltrials.gov/ct2/show/NCT04465565
Feb 22nd, 2022 - The diagnosis of Growth Hormone deficiency in childhood requires the performance of an artificial pharmacological stimulation tests. There are number of substances that increase the secretion of growth hormone, among them Clonidine and Arginine. O...
https://clinicaltrials.gov/ct2/show/NCT04806854
Jan 24th, 2022 - This trial will have a single screening visit to assess if subjects are eligible to start study therapy. Once subjects have completed screening, and if they are determined to be eligible, they will return to the clinic for a 12-hour pulsatility st...
https://clinicaltrials.gov/ct2/show/NCT02781727
Jan 4th, 2022 - A 52 week trial of TransCon hGH, a long-acting growth hormone product, versus human growth hormone therapy. TransCon hGH will be given once-a-week, human growth hormone (hGH) will be given daily. Approximately 150 prepubertal, hGH-treatment naïve ...
News 63 results
https://www.medscape.com/viewarticle/958043
Sep 2nd, 2021 - The US Food and Drug Administration (FDA) has approved lonapegsomatropin (Skytrofa, Ascendis Pharma), the first weekly subcutaneous injectable growth hormone for children with growth hormone deficiency (GHD). The approval was based on the findings...
https://www.medpagetoday.com/endocrinology/generalendocrinology/92929
Jun 6th, 2021 - The investigational dual GIP and GLP-1 receptor agonist tirzepatide significantly reduced HbA1c levels and induced weight loss in patients with type 2 diabetes compared with insulin glargine in the SURPASS-4 trial, Eli Lilly announced. A randomize...
https://www.medscape.com/viewarticle/947349
Mar 12th, 2021 - Children who have been treated for brain tumors often experience significant weight gain, and new findings suggest that this could be a sign of hypothalamic-pituitary (HP) dysfunction. "We believe that endocrine surveillance should be initiated ea...
https://www.staging.medscape.com/viewarticle/940135
Nov 2nd, 2020 - Endocrine diseases of any type — not just diabetes — can represent a cardiovascular risk and patients with those disorders should be screened for high cholesterol, according to a new clinical practice guideline from the Endocrine Society. "The sim...
https://www.medpagetoday.com/endocrinology/generalendocrinology/88571
Sep 11th, 2020 - For people with type 2 diabetes, drinking more than one alcoholic beverage per day was associated with an increased risk for high blood pressure. (Journal of the American Heart Association) The phase III LOGICS trial met its primary endpoint, demo...
